Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital

Sponsor

Assiut University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05002166

Collaborator

(none)

Enrollment

Location

71.5

Anticipated Duration (Months)

0.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Clinical Characteristics and Risk factors of Children Suffering from Inflammatory Bowel Diseases At Assiut University Children Hospital

Condition or Disease	Intervention/Treatment	Phase
Inflammatory Bowel Disease	Other: labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

Detailed Description

All patients admitted with inflammatory bowel disease will be subjected to:

History: including name, age ,sex ,family history, consanguinity, history of rectal bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting ,nausea and loss of appetite.
Examination: including general examination, chest, cardiac, abdominal and neurological examination
Investigation:including labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

Study Design

Study Type:

Observational

Anticipated Enrollment :

20 participants

Observational Model:

Other

Time Perspective:

Prospective

Official Title:

Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital

Anticipated Study Start Date :

Aug 5, 2021

Anticipated Primary Completion Date :

Jul 20, 2027

Anticipated Study Completion Date :

Jul 20, 2027

Arms and Interventions

Arm	Intervention/Treatment
Children aged less than 18 years with a confirmed diagnosis of IBD. All patients admitted with inflammatory bowel disease will be subjected to: History: including name, age ,sex ,family history, consanguinity, history of rectal bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting ,nausea and loss of appetite. Examination: including general examination, chest, cardiac, abdominal and neurological examination Investigation:including labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.	Other: labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope. labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

Arm

Intervention/Treatment

Children aged less than 18 years with a confirmed diagnosis of IBD.

All patients admitted with inflammatory bowel disease will be subjected to: History: including name, age ,sex ,family history, consanguinity, history of rectal bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting ,nausea and loss of appetite. Examination: including general examination, chest, cardiac, abdominal and neurological examination Investigation:including labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

Other: labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

Outcome Measures

Primary Outcome Measures

Clinical characteristics and risk factors for IBD [6 months]
To study the natural history, patterns, and clinical characteristics (as history of real bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting)and risk factors of inflammatory bowel diseases (IBD) at Assiut University Children Hospital

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A to 18 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Children aged less than 18 years with a confirmed diagnosis of IBD.

Exclusion Criteria:

Children with colitis other than IBD or children with systemic diseases affecting GIT.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Christine zaghloul noos	Assiut		Egypt	23123

Sponsors and Collaborators

Assiut University

Investigators

Principal Investigator: Shereen Mansour, Lecturer, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Christine Zaghloul Noos, Principal investigator, Assiut University

ClinicalTrials.gov Identifier:

NCT05002166

Other Study ID Numbers:

Infilamatory bowel disease

First Posted:

Aug 12, 2021

Last Update Posted:

Aug 12, 2021

Last Verified:

Jul 1, 2021

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Intestinal Diseases

Inflammatory Bowel Diseases

Study Results

No Results Posted as of Aug 12, 2021